Message Boards | Biotechnology : Provectus Pharmaceuticals Inc. -- Ignore unavailable to you. Want to Upgrade?


Public Reply | Prvt Reply | Mark as Last Read | File | KeepPrevious 10 | Next 10 | Previous | Next
From: pvct investor10/1/2009 2:42:43 PM
2 Recommendations  Read Replies (1) of 6902
 
Maxim Group Updates Research Report on Provectus: PV-10 clinical development expands into liver cancer; Reiterate Buy rating

Report TOU ViolationEmail This Page 
Public Reply | Prvt Reply | Mark as Last Read | File | KeepPrevious 10 | Next 10 | Previous | Next


Copyright © 2009 TZ Holdings LLC. All rights reserved.